Protocol AI463203: A Study of the Safety and Efficacy of Entecavir plus Tenofovir in Adults with Chronic Hepatitis B Virus Infection with Previous Nucleoside/Nucleotide Treatment Failure

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-015705-40

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To describe the efficacy of the combination therapy of ETV plus TDF at 48 weeks of treatment, in control of viral load (HBV DNA < 50 IU/mL) in chronic HBV infected subjects who have failed previous treatment


Critère d'inclusion

  • Chronic Hepatitis B Virus Infection